FDA Inspection 1253475 — Lundbeck Pharmaceuticals LLC
The FDA completed an inspection of Lundbeck Pharmaceuticals LLC on Oct 25, 2024 in Deerfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 25, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Deerfield, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)